Bombinin H-BO

General Information


DRACP ID  DRACP00724

Peptide Name   Bombinin H-BO

Sequence  IIGPVLGLIGKALGGLL

Sequence Length  17

UniProt ID  Not available

PubChem CID  Not available

Origin  skin secretion of Oriental fire-bellied toad, Bombina orientalis

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
SK-HEP-1 Liver and intrahepatic bile duct epithelial neoplasm Carcinoma IC50=0.99 μM MTT assay 48h 1
Hep-G2 Hepatoblastoma; Hepatoblastoma Blastoma IC50=2.88 μM MTT assay 48h 1
Huh-7 Adult hepatocellular carcinoma; Adult hepatocellular carcinoma Carcinoma IC50=1.81 μM MTT assay 48h 1

Hemolytic Activity  Human erythrocytes: Bombinin H-BO was found to lyse 38% of erythrocytes at concentration of 80.0 μm (128 mg/ml), and up to 85% at the concentration of 159.7 μm (256 mg/ml).

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00724

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C77H138N18O18

Absent amino acids  CDEFHMNQRSTWY

Common amino acids  GL

Mass  188966

Pl  9.7

Basic residues  1

Acidic residues  0

Hydrophobic residues  10

Net charge  1

Boman Index  4436

Hydrophobicity  182.35

Aliphatic Index  206.47

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 28636781

Title  Discovery of two bombinin peptides with antimicrobial and anticancer activities from the skin secretion of Oriental fire-bellied toad, Bombina orientalis

Doi 10.1111/cbdd.13055

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.